NCT05919264: An ongoing trial by Parabilis Medicines, Inc.
This trial is ongoing. It must report results 2 years, 3 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05919264 |
|---|---|
| Title | A Phase 1/2 Study of FOG-001 in Participants With Locally Advanced or Metastatic Solid Tumors |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | May 23, 2023 |
| Completion date | April 1, 2027 |
| Required reporting date | March 31, 2028, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |